Hunting Hill Global Capital, LLC Amarin Corp Plcuk Transaction History

Hunting Hill Global Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $63,828 - $94,608	-16,200 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.26 - $6.5 $69,012 - $105,300	16,200 New	16,200 $71,000
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $3,048 - $5,332	-606 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.04 - $5.31 $37,951 - $49,882	-9,394 Reduced 93.94%	606 $3,000
Q3 2020 Nov 16, 2020	BUY	$3.64 - $7.76 $36,400 - $77,600	10,000 New	10,000 $42,000

181

68.6M

192K

78.1K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $246M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Hunting Hill Global Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hunting Hill Global Capital, LLC with notifications on news.